不用本金就能赚钱的方法

来宝网Logo

热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

现在位置不用本金就能赚钱的方法>技术资料不用本金就能赚钱的方法>行业动态>招商代理>Luminex与EMD Millipore扩展全球分销协议

Luminex与EMD Millipore扩展全球分销协议

Luminex2013年5月30日 7:33 点击:1906

美国 Luminex EMD Millipore
不用本金就能赚钱的方法 2013年5月28日 Luminex公司表示,扩大了其与EMD Millipore的全球供应和分销协议。

不用本金就能赚钱的方法  EMD MilliporeWEIMOKESHENGMINGKEXUEBU,GAIJIAOYIYUJIJIANGJINYIBUTISHENGEMD MilliporeGONGSIDANBAIZHIJIANCEJISHUZAILuminexGONGSIxMAPPINGTAIDEYINGYONG。EMD MilliporeYEJIANGJIXUTIGONGLuminexGONGSISUOYOUDExMAPXITONG,BAOKUOMagpix、Luminex 100/200,HEFlexmap 3D。

  YOUGUANCICIXIEYIDECAIWUJIQITAJIAOYITIAOKUANSHANGWEIPILU。

  “TONGLuminexGONGSIHEZUOGUANXIDEGENGXIN,JIANGQUEBAOEMD MilliporeWEILAIJINIANWEIKEHUTIGONGFUDANBAIJIANCEDEWANZHENGJIEJUEFANGAN,BAOKUOJIANCESHIJIHE,YIQI,RUANJIANHEFUWU。” John Sweeney,EMD MilliporeSHENGMINGKEXUEYEWUFUZERENZAIYIFENSHENGMINGZHONGSHUO。

 

Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement

AUSTIN, Texas, May 28, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced it has extended their global supply and distribution agreement with EMD Millipore—the Life Science division of , Darmstadt, Germany. This long-term agreement strengthens the partnership and facilitates development of life science and protein assays by EMD Millipore for Luminex's flexible platform.

(Logo: )

"We are very pleased to extend our global supply and distribution agreement with EMD Millipore, a leader in life science and protein research," said  Michael F. Pintek, senior vice president of operations at不用本金就能赚钱的方法Luminex. "EMD Millipore's broad selection of protein biomarkers in diverse research areas such as cancer, cell signaling, cellular metabolism, and immunology reflects their leadership in the life science research market. Together we can accelerate the pace of research and advance healthcare for people around the world."

As part of the agreement, EMD Millipore will continue to offer the full range of Luminex's xMAP® systems, including MAGPIX®, Luminex® 100/200™, and FLEXMAP 3D®. Luminex Technology is widely supported and validated across both clinical and life science research markets, with cumulative shipments to date nearing 10,000 total instruments and over 16,000 publications across a broad spectrum of applications. 

"EMD Millipore is committed to continue bringing to researchers the largest selection of assays and analytes for Luminex's instrument portfolio," said  John Sweeney, head of life sciences business at EMD Millipore. "This renewal of our partnership with Luminex 不用本金就能赚钱的方法ensures that EMD Millipore can provide customers with a complete solution for multiplexed protein detection—encompassing assay kits, instruments, software and services—that will support them over the years."

EMD Millipore, a leader in multiplex assay kit development, has continued to push into emerging areas of research and recently announced the availability of MILLIPLEX® map human stem cell pluripotency kits and MILLIPLEX® map kits for cellular metabolism. Compared with traditional biomarker detection techniques such as western blots, these new kits increase assay throughput and specificity. Additionally, EMD Millipore recently released the newest version of their best-in-class multiplex data analysis package, MILLIPLEX® Analyst 5.1 software—one of the most robust data analysis tools available today for Luminex® platform-based multiplexed immunoassays.  

About Luminex Corporation

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture—multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies—that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award-winning technology, please visit .

Contacts:

Luminex Investor Contact: 
Matthew Scalo, 512.219.8020 
Sr. Director Investor Relations 
mscalo@luminexcorp.com

Luminex Media Contact: 
Mimi Torrington, 512.219.8020
Director of Marketing Communications
mtorrington@luminexcorp.com

 


不用本金就能赚钱的方法  

SOURCE Luminex Corporation

(来源: Luminex )


全年征稿 / 资讯合作

联系邮箱:kefu@strauss-usa.com不用本金就能赚钱的方法

BANQUANYUMIANZESHENGMING

  • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://strauss-usa.com,违反者本网将追究相关法律责任。
  • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
  • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。
湖南快乐十分 湖南快乐十分 福建快3走势图0 福建快3走势图 河南快3走势图 河南快3走势图 广东11选5开奖结果 福建11选5走势图